ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,748Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 623

$870K Total Retail Price of All Prescriptions

Rank: 8 out of 623

526 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 526 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 526 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 10,686 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 447 386 1 3
LEVOTHYROXINE SODIUM 443 326 2 4
OMEPRAZOLE 436 333 3 7
METOPROLOL TARTRATE 380 319 4 9
SIMVASTATIN 379 285 5 2
FUROSEMIDE 367 267 6 5
LISINOPRIL 365 273 7 1
HYDROCODONE-ACETAMINOPHEN 312 187 S3 8 17
POTASSIUM CHLORIDE 217 196 9 24
METFORMIN HCL 206 147 10 6
ATORVASTATIN CALCIUM 191 123 11 10
TRAMADOL HCL 188 139 12 15
JANTOVEN 184 93 13 54
HYDROCHLOROTHIAZIDE 181 130 14 8
DIGOXIN 174 163 15 63
GABAPENTIN 165 82 16 18
CLOPIDOGREL 162 127 17 34
ZOLPIDEM TARTRATE 162 73 17 22
PRAVASTATIN SODIUM 160 129 19 11
WARFARIN SODIUM 154 135 20 14
CITALOPRAM HBR 148 101 21 21
RAMIPRIL 148 133 21 79
METOPROLOL SUCCINATE 141 104 23 13
SERTRALINE HCL 140 90 24 20
RANITIDINE HCL 138 71 25 23
LOSARTAN POTASSIUM 134 95 26 16
CARVEDILOL 126 94 27 32
GLIMEPIRIDE 115 90 28 38
PROAIR HFA 114 67 29 57
ALLOPURINOL 113 100 30 44
IBUPROFEN 110 53 31 68
ENALAPRIL MALEATE 106 103 32 73
PLAVIX 103 84 33 46
AMOXICILLIN 101 71 34 98
RISPERIDONE 101 99 34 49
TRAZODONE HCL 100 33 36 36
NEXIUM 95 49 37 43
MIRTAZAPINE 94 81 38 31
PANTOPRAZOLE SODIUM 90 54 39 26
OXYCODONE HCL 87 34 S2 40 30
DIOVAN 86 71 41 48
CYCLOBENZAPRINE HCL 86 29 R 41 65
SPIRIVA 85 73 43 58
NAPROXEN 82 32 44 89
PAROXETINE HCL 80 53 45 66
QUETIAPINE FUMARATE 79 64 46 51
CRESTOR 78 50 47 28
TAMSULOSIN HCL 78 58 47 35
AZITHROMYCIN 76 66 49 45
FENOFIBRATE 76 37 49 71
LANTUS 75 58 51 41
ESCITALOPRAM OXALATE 75 57 51 60
TRIAMTERENE-HCTZ 74 74 53 74
ADVAIR DISKUS 73 50 54 39
VERAPAMIL ER 73 46 54 104
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 62 56 19
NITROGLYCERIN PATCH 70 59 57 145
DONEPEZIL HCL 66 66 58 27
BENICAR 65 64 59 161
OXYBUTYNIN CHLORIDE 64 43 60 134
ISOSORBIDE MONONITRATE ER 63 51 61 64
ZETIA 62 56 62 99
ALBUTEROL SULFATE 62 54 62 69
LOPERAMIDE 62 50 62 215
BENAZEPRIL HCL 62 33 62 106
LOVASTATIN 61 43 66 25
NOVOLOG 60 47 67 75
CYMBALTA 60 15 67 52
AMLODIPINE BESYLATE-BENAZEPRIL 59 55 69 92
ATENOLOL 56 52 70 12
INSULIN SYRINGE 56 50 70 80
FELODIPINE ER 56 56 70 154
PROCHLORPERAZINE MALEATE 55 50 73 267
CEPHALEXIN 54 43 74 102
FAMOTIDINE 54 29 74 112
KLOR-CON M20 54 19 74 62
OXYCODONE-ACETAMINOPHEN 54 42 S2 74 42
PRAMIPEXOLE DIHYDROCHLORIDE 53 31 78 279
VENLAFAXINE HCL ER 51 20 79 96
NAMENDA 50 50 80 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.